Pfizer in Q1 Profit Leap of 61%

Global sales of Pfizer’s coronavirus vaccine and treatment drove the drug maker into new territory in the first quarter of 2022 as profit grew 61 percent on the back of a 77 percent overall revenue leap.


Pfizer Partner Looking to Mix mRNA Vaccine with Chinese Products

China’s state-run Global Times on Thursday reported that BioNTech, the German company that partnered with American company Pfizer to produce its coronavirus vaccine, is “considering to evaluate” mixing its mRNA product with the vaccine manufactured by China’s Fosun Pharma.


FDA Approves Pfizer’s Coronavirus Vaccine

The Food and Drug Administration (FDA) on Friday night approved the first coronavirus vaccine for emergency use in the United States, several media outlets reported, clearing the way for U.S. officials to begin vaccinating millions of Americans as early as next week.

Pfizer has said it will be able to supply up to 25 million doses before the end of the yea